Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Short interest in Hims & Hers Health Inc rose to a record high, even as shares surged following strong first-quarter results.

WeightWatchers filed for bankruptcy on Tuesday as Americans shunned its offerings in favor of Novo and Lilly drugs and copies ...

Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers ...

Former Meta and Time Warner exec Mark D'Arcy is joining Microsoft as a corporate vice president working on the tech ...

Today's Forbes Daily newsletter covers billionaire security squads, Bill Gates’ 99% pledge, new Hims & Hers billionaire, ...

Hims & Hers Health (NYSE:HIMS) priced its offering of $870M aggregate principal amount of 0.00% convertible senior notes due ...

Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.

Nader Kabbani, who led the launch of Amazon Pharmacy and the acquisition of PillPack, will take the chief operating officer ...

Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.

As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding ...